NCT06262464 An OCD Prevention Programme for at Risk Adults
| NCT ID | NCT06262464 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Babes-Bolyai University |
| Condition | Obsessive-Compulsive Disorder |
| Study Type | INTERVENTIONAL |
| Enrollment | 200 participants |
| Start Date | 2024-02-09 |
| Primary Completion | 2025-07-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 200 participants in total. It began in 2024-02-09 with a primary completion date of 2025-07-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The main purpose of this randomised clinical trial is to test the efficacy of a prevention program for adult who are at risk of developing OCD, thus constituting a form of tertiary prevention.
Eligibility Criteria
Inclusion Criteria: \- age over 18 Exclusion Criteria: * clinically diagnosed OCD * current psychiatric/psychotherapeutic treatment * personality disorder diagnosis * suicidal ideation
Contact & Investigator
Roxana Cardoș, PhD
PRINCIPAL INVESTIGATOR
Babeș-Bolyai University
Frequently Asked Questions
Who can join the NCT06262464 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 65 Years, studying Obsessive-Compulsive Disorder. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06262464 currently recruiting?
Yes, NCT06262464 is actively recruiting participants. Contact the research team at roxanaoltean@psychology.ro for enrollment information.
Where is the NCT06262464 trial being conducted?
This trial is being conducted at Cluj-Napoca, Romania.
Who is sponsoring the NCT06262464 clinical trial?
NCT06262464 is sponsored by Babes-Bolyai University. The principal investigator is Roxana Cardoș, PhD at Babeș-Bolyai University. The trial plans to enroll 200 participants.